Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: TALIS BIOMEDICAL CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-07-30 to 2022-01-30
Current total value of award: $17250000
Description: EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI DE-OBLIGATION OF NO-YEAR FUNDS FOR RAPID ACCELERATION OF DIAGNOSTICS (RADX) SARS-COV-2